Loading…
Support Peaceful Protest Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
75pct
50d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Support Peaceful Protest Act This bill imposes additional penalties upon an individual who is convicted of a federal offense related to conduct during the course of a protest (e.g., rioting). First, in addition to the penalty for the conviction, the individual must pay restitution to cover the cost of federal policing during the protest. Second, the individual is ineligible for pandemic unemployment assistance.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · fourth_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Worker and Family Support.
Referred to the Committee on the Judiciary, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medical/Disease Research/Clinical Labs
Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medical/Disease Research/Clinical Labs
Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Medical/Disease Research/Clinical Labs
Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medical/Disease Research/Clinical Labs
Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Medical/Disease Research/Clinical Labs
Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Firearms/Guns/Ammunition
HR 1210, HR 2690, HR 288, HR 289, HR 1567, HR 3131, HR 3153, HR 3217, S 619, S 1586, S 1597, S 1650,
Client expense: $20,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Medical/Disease Research/Clinical Labs
Lobbied in support of increased federal research funding for the NIH, VA, and DoD's Congressionally Directly Medical Research Program. Lobbied in support of H.R. 289/H.R. 869, the RISE Act, to provide $25 billion in research funding to research facilities whose research was disrupted due to the COVID-19 pandemic.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| TX |
| Mo Brooks | Republican | AL |
| Rick W. Allen | Republican | GA |
| Scott Perry | Republican | PA |
| Ted Budd | Republican | NC |